Who is Domino?

Domino Data Lab empowers the largest AI-driven enterprises to build and operate AI at scale. Domino’s Enterprise AI Platform provides an integrated experience encompassing model development, MLOps, collaboration, and governance. With Domino, global enterprises can develop better medicines, grow more productive crops, develop more competitive products, and more. Founded in 2013, Domino is backed by Sequoia Capital, Coatue Management, NVIDIA, Snowflake, and other leading investors.

Watch Demo

Episode 90

Pharma is the new tech: The future of AI in life sciences

Data Science Leaders | 31:41 | March 13, 2025

Listen how you want

Listen onSpotify

Listen onApple

Listen onYouTube

Return to podcast home

AI is transforming drug discovery and clinical trials, making what was once cutting-edge the new standard. Pharma companies are evolving into tech companies, leveraging AI to revolutionize every phase of drug development.

In this episode, Chris McSpiritt, VP of Life Sciences Strategy at Domino, discusses how AI is no longer a niche capability for select firms but an essential capability for all biopharma organizations. We explore AI-based digital organisms, the increasing reliance on AI in clinical trials, and the shift toward personalized medicine.

Join us as we dive into: